Biomarker Sciences Program

The Biomarker Sciences Program exists to support the clinical research of the two other scientific programs in the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). This program contains five scientific groups, by specialty: the Data Science Committee, Developmental Therapeutics Committee, Imaging Diagnostics and Biomarker Committee, Laboratory Science and Pathology Committee, and Germline Genomics Committee. Together, researchers in this program:

  • Evaluate and integrate cross-cutting biologic science opportunities
  • Attract basic and translational science from member and external organizations
  • Foster translational and correlative science across the Group

The Biomarker Steering Committee, shown below, guides the program and the cross-committee interactions among researchers.

Biomarker Steering Committee



Chair

Represents the program as a deputy chair on the Executive Committee

Co-Chair

Keith T. Flaherty, MD

Harvard University/Mass General Cancer Center
Biography

Biomarker Sciences ProgramBiomarker Sciences Program
 

Daniel P. Barboriak, MD

Duke University/Duke Cancer Institute
Biography

Biomarker Sciences ProgramBiomarker Sciences Program
 
ECOG-ACRIN Cancer Research Group